Skip to content
Ipodate
Bilivist, Oragrafin (ipodate) is a small molecule pharmaceutical. Ipodate was first approved as Oragrafin calcium on 1982-01-01.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Ipodate calcium
Tradename
Company
Number
Date
Products
ORAGRAFIN CALCIUMBracco DiagnosticsN-012968 DISCN1982-01-01
1 products
Hide discontinued
Ipodate sodium
Tradename
Company
Number
Date
Products
ORAGRAFIN SODIUMBracco DiagnosticsN-012967 DISCN1982-01-01
1 products
Hide discontinued
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V08: Contrast media
— V08A: X-ray contrast media, iodinated
— V08AC: Watersoluble, hepatotropic x-ray contrast media
— V08AC08: Sodium iopodate
HCPCS
No data
Clinical
Clinical Trials
1 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Coronary artery diseaseD003324I25.1———1—1
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameIPODATE
INNsodium iopodate
Description
Ipodate sodium (sodium iopodate) is an iodine-containing radiopaque contrast media used for X-rays. The drug is given orally and the resulting contrast allows for easy resolution of the bile duct and gall bladder.
Classification
Small molecule
Drug class—
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CN(C)/C=N/c1c(I)cc(I)c(CCC(=O)O)c1I
Identifiers
PDB—
CAS-ID1221-56-3
RxCUI9887
ChEMBL IDCHEMBL1201243
ChEBI ID81496
PubChem CID23671932
DrugBank—
UNII IDF316LLW9WW (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 79 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
296 adverse events reported
View more details